We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Why Immunotherapy Only Works for Some Patients With Head and Neck Cancer

News   Nov 25, 2020 | Original story from University of Cincinnati

 
Why Immunotherapy Only Works for Some Patients With Head and Neck Cancer

A normal healthy T cell versus a cancer T cell. Credit: Conforti's lab

 
 
Advertisement
 

RELATED ARTICLES

Targeting the Circadian Rhythm Regulator CRY-1 in Prostate Cancer

News

A regulator of circadian rhythms, known as CRY-1 has been shown to promote tumor progression by altering DNA repair.

READ MORE

Biochemical Pathway Discovered That Protects Cells From Ferroptosis

News

In an article published in Cell Metabolism, Moffitt Cancer Center researchers report on a newly discovered biochemical pathway that protects cells from a type of cell death called ferroptosis.

READ MORE

Drug May Reduce Tumor Volume in Neurofibromatosis

News

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE